Abstract
The use of adequate fluid therapy during cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains controversial. The aim of the study was to assess whether the use of fluid therapy protocol combined with goal-directed therapy (GDT) is associated with a significant change in morbidity, length of hospital stay, and mortality compared to standard fluid therapy. Patients American Society of Anesthesiologists (ASA) II–III undergoing CRS and HIPEC were randomized into two groups. The GDT group (N = 38) received fluid therapy according to a protocol guided by monitored hemodynamic parameters. The control group (N = 42) received standard fluid therapy. We evaluated incidence of major complications, total length of hospital stay, total amount of fluids administered, and mortality rate. The incidence of major abdominal complications was 10.5 % in GDT group and 38.1 % in the control group (P = 0.005). The median duration of hospitalization was 19 days in GDT group and 29 days in the control group (P < 0.0001). The mortality rate was zero in GDT group vs 9.5 % in the control group (P = 0.12). GDT group received a significantly (P < 0.0001) lower amount of fluid (5812 ± 1244 ml) than the control group (8269 ± 1452 ml), with a significantly (P < 0.0001) lower volume of crystalloids (3884 ± 1003 vs 68,528 ± 1413 ml). In CRS and HIPEC, the use of a GDT improves outcome in terms of incidence of major abdominal and systemic postoperative complications and length of hospital stay, compared to standard fluid therapy protocol.
Similar content being viewed by others
References
Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995; 221:29-42.
Esquivel J, Sticca R, Sugarbaker P et al.; Society of Surgical Oncology Annual Meeting: Cytoreductive surgery and hypertermic intraperitoneal chemiotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Onc 2007;14:128-133
Gusani NJ, Cho SW, Colovos C, et al: Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high volume tertiary cancer center. Ann Surg Oncol 2008; 15: 754-763
Baratti D, Kusamura S, Laterza B, Balestra MR, Deraco M: Early and long term postoperative management following cytoreductive surgery and hypertermic intraperitoneal chemotherapy. World J Gastrointest Oncol 2010;2:36-43.
Esquivel J, Angulo F, Bland R, Stephens A D, Sugarbaker PH: Hemodynamic and cardiac function parameters during heated intraperitoneal chemotherapy using the open coliseum technique. Ann Surg Onc 2000; 74:296-300.
Kanakoudis F, Petrou A, Michaloudis D, Chortaria G, Konstantinidou A: Anaesthesia for intra-peritoneal perfusion of hypertermic chemotherapy. Anaesthesia 1996; 51:1033-1036.
Raspe C, Piso O, Wiesenack C, Buchera M: Anesthetic management in patients undergoing hyperthermic chemotherapy. Curr Op Anesthsiol 2012; 25:348-55
Donati A, Loggi S, Preiser JC, et al Goal directed intraoperative therapy reduces morbidity and length of hospital stay in high risk surgical patients. Chest 2007; 132:1817-1824.
Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennet ED: Early goal directed therapy after major surgery reduces complication and hospital stay. A randomized controlled trial. Crit Care 2005; 9: R687-R693.
Lopes MR, Oliveira MA, Pereira VO, Lemos IP, Auler JO, Michard F: Goal-directed fluid management based on pulse pressure variation monitoring during high risk surgery: a pilot randomized trial. Crit Care 2007; 11:R100.
Giglio MT, Marucci M, Testini M, Brienza N: Goal-directed haemodynamic therapy and gastrointestinal complication in major surgery: a meta-analysis of randomized controlled trial. Br J Anaesth 2009; 103:637-646.
Shime N, Lee M, Hatanaka T: Cardiovascular changes during continuous hypertermic peritoneal perfusion. Anesth Analg 1994; 78:938-942.
Sugarbaker PH: Peritonectomy procedures. Surg Oncol Clin N Am 2003;12:703–727.
Lees N, Hamilton M, Rhodes A: Clinical review: Goal directed therapy in high risk surgery patients. Crit Care 2009; 13:231.
Shoemaker WC, Appel PL, Kram HB, Waxman K, Lees TS: Prospective trial of supranormal values of survivor as therapeutic goals in high risk surgical patients. Chest 1988, 94:1176-1186.
Mackenzie SJ: Should perioperative management target oxygen delivery? Br J Anaesth 2003; 91:615-618.
Lugo G, Arizpe D, Domínguez G, Ramírez M, Tamariz O Relationship between oxygen consumption and oxygen delivery during anesthesia in high-risk surgical patients. Crit Care Med. 1993 Jan; 21(1):64-9.
EP Rivers, M Katranji, KA Jaehne, S Brown et al. Early intervention in sever sepsis and septic shock: a review of the evidence one decade later. Minerva Anestesiol. 2012 Jun;78:712-24
Jafari MD, Halabi WJ, Stamos MJ, Nguyen VQ. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program. JAMA Surg. 2014 Feb 1;149:170-5.
Brandstrupp B, Tønnesen H, Beier-Holgersen R, et al. Effect of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens. Ann Surg 2003; 238: 641-648.
Lobo S, Ronchi L, Oliveira N, et al. Restrictive strategy of intraoperative fluid maintenance during optimization of oxygen delivery decreases major complications after high risk surgery. Crit Care 2011; 15:R226.
Nisavenich V, Felsenstein I, Almogy G, Weissman C, et al.: Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology 2005; 103:25-32.
Boland MR, Noorani A, Varty K, Coffey JC, et al. Perioperative Fluid Restriction in Major Abdominal Surgery: Systematic Review and Meta-analysis of Randomized, Clinical Trials World J Surg 2013; 37:1193–1202
Varadhan KK, Lobo DN. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc 2010; 69:488–498
Abraham-Nordling M, Hjern F, Pollack J, Prytz M, et al. Randomized clinical trial of fluid restriction in colorectal surgery. Br J Surg 2012; 99:186–191
Nygren J, Thacker J, Carli F, Fearon KC et al. Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations World J Surg 2013;37: 285–305
Lassen K, Marielle M, Coolsen E, Slim K, et al. Guidelines for Perioperative Care for Pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS) Society Recommendations World J Surg 2013;37; 240–25
Schmidt C, Moritz S, Rath S, et al: Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol 2009; 100: 297-301
Hadian M, Pinsky MR: Functional hemodynamic monitoring. Curr Opin Crit Care 2007;13:318-323
Benes J, Chytra I, Altmann P, et al: Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study. Crit Care 2010; 14:R118
Chowdhury AH, Lobo DN: Fluids and gastrointestinal function. Curr Opin Clin Nutr Metab Care 2011;14:469-476.
Hiltebrand L, Kimberger O, Arnberger M, Brandt S, Kurz A, Sigurdsson GH: Crystalloids versus colloids for goal directed therapy in major surgery. Crit Care 2009;13: R40.
Kimberger O: Goal directed colloid administration improves the microcirculation of healthy and perianastomotic colon. Anesthesiology 2009; 110:496-450
Acknowledgments
Departmental funding only.
Conflict of Interest
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Colantonio, L., Claroni, C., Fabrizi, L. et al. A Randomized Trial of Goal Directed vs Standard Fluid Therapy in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. J Gastrointest Surg 19, 722–729 (2015). https://doi.org/10.1007/s11605-015-2743-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-015-2743-1